{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:50:27Z","timestamp":1792698627304,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T00:00:00Z","timestamp":1533340800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/jac\/dky259","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T15:14:54Z","timestamp":1528989294000},"page":"2643-2651","source":"Crossref","is-referenced-by-count":55,"title":["Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins"],"prefix":"10.1093","volume":"73","author":[{"given":"Monique R","family":"Bidell","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimish","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-1385","authenticated-orcid":false,"given":"J Nicholas","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"key\n\t\t\t\t20180921035229_dky259-B1","first-page":"362","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180921035229_dky259-B2","first-page":"547","article-title":"Staphylococcus aureus bacteremia, risk factors, complications, and management","volume":"29","author":"Keynan","year":"2013","journal-title":"Crit Care Clin"},{"key":"key\n\t\t\t\t20180921035229_dky259-B3","first-page":"1288","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20180921035229_dky259-B4","first-page":"1435","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180921035229_dky259-B5","first-page":"e26","article-title":"2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B6","first-page":"1","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B7","first-page":"S246","article-title":"Patients at risk of complications of Staphylococcus aureus bloodstream infection","volume":"48","author":"del Rio","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B8","first-page":"1539","article-title":"Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study","volume":"70","author":"Bai","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B9","first-page":"e474","article-title":"Impact of prior healthcare-associated exposure on clinical and molecular characterization of methicillin-susceptible Staphylococcus aureus bacteremia: results from a retrospective cohort study","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180921035229_dky259-B10","first-page":"5122","article-title":"Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?","volume":"55","author":"Lee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B11","first-page":"1581","article-title":"Are all \u03b2-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","author":"Paul","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180921035229_dky259-B12","first-page":"4684","article-title":"Cefazolin versus nafcillin for methicillin-sensitive Staphylococcus aureus bloodstream infection in a California tertiary medical center","volume":"60","author":"Pollett","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B13","first-page":"5232","article-title":"Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections","volume":"59","author":"Rao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B14","first-page":"63","article-title":"High-dose cefazolin on consecutive hemodialysis in anuric patients with staphylococcal bacteremia","volume":"15","author":"Renaud","year":"2011","journal-title":"Hemodial Int"},{"key":"key\n\t\t\t\t20180921035229_dky259-B15","first-page":"107","article-title":"Definitive treatment for methicillin-susceptible Staphylococcus aureus bacteremia: data versus a definitive answer?","volume":"65","author":"Karchmer","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B16","first-page":"125","article-title":"Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review","volume":"24","author":"Loubet","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180921035229_dky259-B17","first-page":"346","article-title":"\u03b2-Lactam therapy for methicillin-susceptible Staphylococcus aureus bacteremia: a comparative review of cefazolin versus antistaphylococcal penicillins","volume":"37","author":"Li","year":"2017","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180921035229_dky259-B18","first-page":"344","article-title":"Effect of inoculum and of \u03b2-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins","volume":"8","author":"Sabath","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B19","first-page":"229","article-title":"The inoculum effect: fact or artifact?","volume":"50","author":"Craig","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B20","first-page":"152","article-title":"Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea","volume":"24","author":"Lee","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180921035229_dky259-B21","first-page":"4474","article-title":"Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus","volume":"56","author":"Livorsi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B22","first-page":"6928","article-title":"Association between type A blaZ gene polymorphism and cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus","volume":"60","author":"Lee","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B23","article-title":"The prevalence of an inoculum effect with cefazolin and the association with certain blaZ gene types among methicillin-susceptible Staphylococcus aureus isolates from four major Chicago medical centers","volume":"3","author":"Wang","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B24","first-page":"568","article-title":"Clinical implications of cefazolin inoculum effect and \u03b2-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia","volume":"20","author":"Lee","year":"2014","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20180921035229_dky259-B25","first-page":"3437","article-title":"Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure","volume":"53","author":"Nannini","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B26","first-page":"225","article-title":"The safety and economic impact of cefazolin versus nafcillin for the treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections","volume":"6","author":"Flynt","year":"2017","journal-title":"Infect Dis Ther"},{"key":"key\n\t\t\t\t20180921035229_dky259-B27","first-page":"369","article-title":"Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting","volume":"59","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B28","first-page":"533","article-title":"Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition","volume":"23","author":"Harris","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180921035229_dky259-B29","first-page":"603","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t20180921035229_dky259-B30","first-page":"557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180921035229_dky259-B31","first-page":"272","article-title":"Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin\/tazobactam: a systematic review and meta-analysis","volume":"56","author":"Falagas","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B32","first-page":"5117","article-title":"Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035229_dky259-B33","first-page":"100","article-title":"Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","volume":"65","author":"McDanel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B34","first-page":"349","article-title":"Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome","volume":"34","author":"Chong","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B35","first-page":"285","article-title":"Characteristics of cefazolin inoculum effect-positive methicillin-susceptible Staphylococcus aureus infection in a multicentre bacteraemia cohort","volume":"36","author":"Song","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180921035229_dky259-B36","first-page":"2773","article-title":"Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals","volume":"68","author":"Rinc\u00f3n","year":"2013","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/10\/2643\/25770405\/dky259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T04:25:21Z","timestamp":1537503921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/10\/2643\/5066380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,8,3]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky259","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,8,3]]}}}